Check out our most popular compounded medications! Get Started
The Estradiol 0.5 mg/Estriol 2.0 mg Vaginal Suppository is a solid dosage form designed for insertion into the vaginal cavity. Upon insertion, the suppository dissolves or melts, releasing the active ingredients, estradiol and estriol, for local absorption. This formulation is specifically compounded to address conditions such as atrophic vaginitis, which is often a result of estrogen deficiency in postmenopausal women. Additionally, it may be used in the management of menopausal symptoms and in the treatment of vulvar and vaginal atrophy. The combination of estradiol and estriol in this suppository aims to provide relief from the discomforts associated with these disease states, by replenishing local estrogen levels and promoting healthy vaginal tissue.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Estradiol 0.5 mg/Estriol 2.0 mg Vaginal Suppository is a compounded medication specifically designed to deliver a combination of estrogen hormones directly to the vaginal tissue. This solid dosage form is carefully inserted into the vagina, where it dissolves or melts, allowing the active ingredients to be absorbed locally or systemically. The use of both estradiol and estriol in this formulation aims to harness the benefits of two different estrogens, potentially offering a broader range of therapeutic effects.
Estradiol is a potent form of estrogen and is identical to the hormone produced by the ovaries. It is commonly used in hormone replacement therapy to alleviate symptoms associated with menopause, such as vaginal dryness, itching, and burning. Estriol, on the other hand, is a weaker estrogen that is thought to have a more selective action on the vaginal and urinary tissues, which can be beneficial in treating urogenital symptoms without exerting strong systemic effects.
The combination of estradiol and estriol in a vaginal suppository form allows for targeted delivery to the affected area, which can lead to improved vaginal tissue health, increased lubrication, and relief from atrophic vaginitis. Additionally, this localized approach may reduce the risk of systemic side effects compared to oral hormone replacement therapies. The suppository form is also advantageous for patients who may have difficulties with oral administration or for those who prefer to avoid systemic absorption of hormones.
It is important for both patients and prescribers to understand that this formulation is compounded based on individual needs and should be used under the guidance of a healthcare professional. The specific dose and combination of estradiol and estriol have been chosen to address particular symptoms and conditions, and the effectiveness and safety of the treatment should be monitored regularly.
For those considering the use of Estradiol 0.5 mg/Estriol 2.0 mg Vaginal Suppositories, it is crucial to discuss your medical history, current medications, and any concerns with your healthcare provider. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing personalized care and support to our patients and prescribers.
The estradiol 0.5 mg/estriol 2.0 mg vaginal suppository is a compounded medication designed for insertion into the vagina, where it dissolves to release the active hormones for local absorption. Estradiol and estriol are forms of estrogen, a female hormone that regulates various processes in the body. This formulation is commonly used to treat symptoms associated with menopause, such as vaginal atrophy, dryness, itching, and burning. It may also be used for conditions that result from estrogen deficiency or for hormone replacement therapy in postmenopausal women.
When considering the use of this formulation, it is important to be aware of potential drug interactions. Estrogens can interact with a variety of medications, potentially altering their effects or increasing the risk of adverse reactions. For example, the concurrent use of estrogens with corticosteroids may increase the risk of edema, especially in patients with conditions such as heart disease or kidney disorders. Patients should inform their healthcare provider of all medications they are taking, including prescription drugs, over-the-counter medications, and herbal supplements.
Enzyme inducers, such as certain anticonvulsants (e.g., phenobarbital, phenytoin) and anti-infectives (e.g., rifampicin), can decrease the plasma concentrations of estrogens, potentially reducing the efficacy of the estradiol/estriol suppository. Conversely, enzyme inhibitors, such as certain antifungals (e.g., ketoconazole) and antibiotics (e.g., erythromycin), may increase plasma concentrations of estrogens, potentially leading to an increased risk of side effects.
Estrogens may also interfere with the metabolism of other hormones, such as thyroid hormones, necessitating adjustments in the dosing of thyroid replacement therapy. Additionally, estrogens can potentiate the effects of anticoagulant drugs (e.g., warfarin), which may require closer monitoring of coagulation parameters and possible dose adjustments of the anticoagulant.
Grapefruit juice may increase the concentration of estrogens and should be consumed with caution or avoided when using this formulation. Smoking tobacco can reduce the effectiveness of estrogen therapy and increase the risk of cardiovascular side effects, especially in women over 35 years of age.
It is also important to note that the use of estrogens has been associated with an increased risk of certain conditions, such as venous thromboembolism, stroke, and certain types of cancers, including breast and endometrial cancer. Patients with a history of these conditions or those at high risk should discuss the use of estrogen therapy with their healthcare provider.
Patients should be advised to report any unusual symptoms or side effects to their healthcare provider promptly. Regular monitoring and follow-up appointments are recommended to assess the effectiveness of the treatment and to detect any adverse effects early on.
If you have any questions or require further information regarding drug interactions or the use of this estradiol/estriol vaginal suppository formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the necessary support and guidance.
The Estradiol 0.5 mg/Estriol 2.0 mg Vaginal Suppository is a solid dosage form designed to be inserted into the vagina, where it dissolves or melts at body temperature. Upon insertion, the suppository base, typically made from a substance like cocoa butter or a glycerinated gelatin, begins to melt or dissolve, allowing the active pharmaceutical ingredients, estradiol and estriol, to be released.
Estradiol and estriol are forms of estrogen, a hormone that plays a critical role in the female reproductive system. In this formulation, estradiol is a potent form of estrogen, while estriol is a weaker form. The combination of these two estrogens can provide a balanced approach to hormone replacement therapy. The use of local estrogen therapy, such as this vaginal suppository, is primarily aimed at treating vaginal symptoms associated with menopause, such as vaginal atrophy, dryness, itching, burning, and pain during intercourse.
When the suppository is inserted into the vagina, the estradiol and estriol are absorbed through the vaginal mucosa directly into the local tissue. This localized delivery system allows for the therapeutic effects of estrogens to be concentrated in the area where they are needed most, which can minimize systemic absorption and potentially reduce the risk of systemic side effects. The local application helps to rejuvenate and maintain the health of the vaginal tissue by promoting thickness of the vaginal walls, increasing natural lubrication, and maintaining the tissue's elasticity and acidity, which can help prevent infections.
For patients, it is important to understand that this treatment is specifically tailored for those who are experiencing menopausal symptoms localized to the vagina. For prescribers, it is crucial to consider the patient's overall health, hormone levels, and risk factors before initiating hormone replacement therapy.
As with any medication, it is essential to use this suppository as directed by a healthcare professional. Patients should be instructed on proper insertion techniques to ensure the medication is delivered effectively. If you have any questions or require further information about the Estradiol 0.5 mg/Estriol 2.0 mg Vaginal Suppository, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to support both patients and prescribers with any inquiries regarding this formulation.
This compounded suppository is designed to deliver a combination of estrogen hormones, estradiol and estriol, directly to the vagina. It is often used to treat symptoms of menopause such as vaginal dryness, itching, and burning.
To use the vaginal suppository, insert it into the vagina, usually before you go to bed, or as directed by your healthcare provider. Wash your hands thoroughly before and after insertion. For best results, follow the specific instructions provided by your pharmacist or doctor.
Storage instructions can vary, so it is important to check with the pharmacy where your medication was compounded. In many cases, suppositories should be kept in a cool place, which may include refrigeration, to maintain their shape and effectiveness.
It is generally recommended to avoid using vaginal suppositories during menstruation. However, you should follow the advice provided by your healthcare provider regarding use during your period.
After insertion, the suppository will begin to melt or dissolve, releasing the medication. Some women may notice relief from symptoms within a few hours, while for others, it may take several days. Consult your healthcare provider if your symptoms do not improve or if they worsen.
Possible side effects can include local irritation, increased vaginal discharge, or systemic hormonal effects such as headache, nausea, or breast tenderness. If you experience any severe side effects or signs of an allergic reaction, contact your healthcare provider immediately.
While the primary use is for the treatment of menopausal symptoms, your healthcare provider may prescribe it for other conditions that benefit from local estrogen therapy. Always use the medication as prescribed for your specific condition.
You may wish to avoid sexual activity immediately after inserting the suppository to ensure the medication has time to be absorbed. Discuss with your healthcare provider any concerns you have regarding sexual activity while using this medication.
It is important to inform your healthcare provider of all medications and supplements you are taking, as certain drugs may interact with hormonal treatments. Your provider will advise you on the safety of using other medications concurrently with the suppository.
If you miss a dose, insert it as soon as you remember. If it is near the time of your next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up without consulting your healthcare provider.
Estradiol and estriol vaginal suppositories are typically not recommended during pregnancy or while breastfeeding. You should discuss potential risks and benefits with your healthcare provider before using any hormonal therapy if you are pregnant or nursing.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository
